Gallebo, Mayco P.
HRN: 27-13-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/19/2025
05/26/2025
IV
300mg
1hr PTOR, Then Q8hrs
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes